Liver Diseases  >>  Hetlioz (tasimelteon)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hetlioz (tasimelteon) / Vanda
NCT01271387: Pharmacokinetics of Tasimelteon in Subjects With Mild or Moderate Hepatic Impairment

Completed
1
29
US
tasimelteon, VEC-162, BMS-214778
Vanda Pharmaceuticals
Hepatic Impairment
08/11
08/11

Download Options